Oral Tirzepatide 2026 — Sublingual + GLP-1 Gum
Two verified needle-free compounded tirzepatide formats in May 2026 — sublingual drops and a GLP-1 gum. Bioavailability, dosing, and how oral compares to injection.
The Two Verified Oral Formats
Both available through verified telehealth in May 2026. Both compounded (NOT FDA-approved).
Sublingual Drops
Liquid compounded tirzepatide held under the tongue for 60-90 seconds for absorption through the sublingual mucosa. Daily administration. Direct Meds is the only verified provider.
GLP-1 Gum
Compounded chewable gum format designed for buccal absorption. Daily chewing schedule. Embody is the only verified provider. Available alongside Embody’s injectable program.
Oral vs Injectable Tirzepatide — Side-by-Side
| Factor | Oral (Sublingual / Gum) | Injectable (Compounded) |
|---|---|---|
| Administration | Daily oral (drops or gum) | Weekly subcutaneous injection |
| Bioavailability | Lower (peptide oral absorption challenges) | Standard subcutaneous bioavailability |
| Clinical trial data | None published for compounded oral tirzepatide | Branded SURMOUNT-1: 20.2% weight loss (compounded data DNE transfer) |
| Needle required | No | Yes (small subcutaneous needle, weekly) |
| Storage | Refrigeration (sublingual); confirm for gum | Refrigeration required |
| Monthly cost | $149-$299/mo | $179-$399/mo |
| Dosing flexibility | Daily — easier to adjust | Weekly — slower titration cycle |
| Adherence pattern | Daily habit (some find easier) | Weekly habit (others find easier) |
| FDA approval status | Compounded — NOT FDA-approved | Compounded — NOT FDA-approved (branded Zepbound IS approved injectable) |
Bioavailability note: The only FDA-approved oral GLP-1 (Wegovy Pill / Rybelsus, oral semaglutide) requires a significantly higher mg dose than injectable to achieve comparable plasma exposure. The same physiology likely applies to oral tirzepatide formats, though no head-to-head trial has been published for the compounded versions.
The Bioavailability Question — Honest Read
Peptides like tirzepatide and semaglutide are large molecules. The gastrointestinal tract is generally hostile to peptide absorption — stomach acid and digestive enzymes degrade them before they reach the bloodstream. This is why injectable GLP-1s have dominated since their introduction: subcutaneous injection bypasses GI degradation and delivers ~100% of the dose into systemic circulation.
Oral GLP-1 has been engineered around this problem. The FDA-approved oral semaglutide (Rybelsus / Wegovy Pill) uses a permeation enhancer (SNAC) to facilitate stomach absorption — but achieves only roughly 0.4-1% bioavailability. To compensate, the oral dose is much larger (e.g., 14mg oral Rybelsus to mimic 1mg injectable Ozempic effect).
Sublingual and buccal (gum) routes attempt a different bypass: absorption through the mucosal tissue under the tongue or inside the cheek, avoiding the stomach entirely. In theory this can produce better bioavailability than swallowed peptides. In practice, for tirzepatide specifically, no published clinical trial has confirmed how much active compound actually reaches the bloodstream by these routes — and compounded versions are not subject to the same bioavailability standards as FDA-approved drugs.
Practical implication: patients choosing a compounded oral format should reasonably expect possibly reduced efficacy compared to injectable. Some patients report they tolerate the daily oral dose better than weekly injection. Others see noticeably less weight-loss response. There is no current way to predict individual response with the compounded oral formats.
When Oral Tirzepatide Is the Right Pick
- Strong needle aversion — you would not start (or would discontinue) injectable therapy
- You travel frequently — oral formats avoid the cold-chain storage problem
- Daily habit ritual fits your lifestyle better than a weekly injection
- You are open to potentially reduced efficacy in exchange for needle-free administration
- You want the trial-proven efficacy (SURMOUNT-1: 20.2% weight loss applies to branded injectable)
- Daily oral schedule does not fit your lifestyle (weekly injection is easier for you)
- You want predictable bioavailability + dosing certainty
- Cost optimization matters — System Labs injectable starts at $179/mo, lower than oral options
The FDA-Approved Oral Alternative — Wegovy Pill
If you want a needle-free GLP-1 backed by FDA approval (not compounded), oral semaglutide is the answer — sold as Wegovy Pill at $149/mo and Rybelsus for type-2 diabetes. Oral semaglutide is a different active ingredient (GLP-1 only, not the dual GIP+GLP-1 of tirzepatide), and the trial-data weight-loss profile is closer to injectable Wegovy than to injectable Zepbound. Tirzepatide-specific properties (dual mechanism, ~50% more weight loss in head-to-head trials) do not transfer to semaglutide.
For most patients comparing the oral options, the question reduces to:
- FDA-approved + oral but lower trial weight loss? → Wegovy Pill (semaglutide), $149/mo
- Compounded oral tirzepatide for the dual-mechanism profile? → Direct Meds sublingual ($224.10/mo) or Embody GLP-1 gum
- FDA-approved + best trial weight loss? → Branded injectable Zepbound (only via injection, see Zepbound vs Wegovy)
Compare All Verified Compounded GLP-1 Programs
Direct Meds + Embody offer needle-free formats; the others offer compounded injectable. Verified May 5, 2026.
Top Compounded Tirzepatide Programs (Including Oral Formats)
Pricing accurate as of May 2026. Click a provider to see current pricing and start a consultation. We may earn a commission — at no extra cost to you. See our affiliate disclosure.
| Provider | Monthly Price | Rating | Action |
|---|---|---|---|
SkinnyRxBest Overall 503A compounded GLP-1 specialistCompounded Tirzepatide + Semaglutide (503A pharmacy) | $199–$399 | ★★★★★4.9 | View Best Offer |
TrimRx Online weight loss program with GLP-1 medicationGLP-1 weight loss program (catalog VERIFY) | From $179/mo | ★★★★☆4.5 | View Best Offer |
MEDViEditor’s Pick Reliable mid-tier compounded GLP-1Compounded Tirzepatide + Semaglutide | $179–$299 | ★★★★☆4.6 | View Best Offer |
DirectMedsBest for Sublingual Sublingual + injectable compounded GLP-1Compounded Sema + Tirz (injectable + sublingual), Sermorelin, NAD+, Epithalon | $179–$399 | ★★★★☆4.5 | View Best Offer |
Ivim HealthBest for Microdosing 360 wellness — branded + compounded + microdosing GLP-1Compounded Sema/Tirz/Liraglutide, microdosing GLP-1, Wegovy/Zepbound/Mounjaro/Ozempic/Saxenda, Wegovy Pill | From $75/mo + $74.99 program fee | ★★★★☆4.7 | View Best Offer |
Eden HealthBest Value Branded + compounded with intro pricingCompounded Sema + Tirz, branded GLP-1, NAD+ (5 formats), Sermorelin, hormone therapy | $149 intro / $229–$249 ongoing | ★★★★☆4.7 | View Best Offer |
Pricing and availability current as of May 2026. We earn a commission if you sign up through our links — at no additional cost to you. See our methodology for how we evaluate providers.
Related Guides
Continue your research with these related independent reviews.
Pick the format that fits your life.
Our quiz routes you to the right provider based on format preference (sublingual, gum, injectable), budget, and timeline.
How this page is reviewed
Editorially reviewed by GLP1CompareHub Editorial Team. We are an independent affiliate publisher — we are not licensed medical providers and this site does not deliver medical advice. Every claim on this page is sourced to a verifiable origin (peer-reviewed study, FDA documentation, live brand-site crawl, or our Katalys partner dashboard).
Affiliate disclosure: We earn a commission when you sign up with a provider through our links — at no extra cost to you. We do not rank providers by what they pay us; we rank by patient fit. Full disclosure. Read our methodology · medical disclaimer.